Orexigen Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

OREX 2.89 +0.13 (4.71%)
price chart
Orexigen Therapeutics, Inc. (NASDAQ:OREX) Price Target Update
Orexigen Therapeutics, Inc. (NASDAQ:OREX): The mean estimate for the short term price target for Orexigen Therapeutics, Inc. (NASDAQ:OREX) stands at $12.8 according to 5 Analysts. The higher price target estimate for the stock has been calculated at ...
Orexigen Therapeutics, Inc. Short Interest Update
Orexigen Therapeutics, Inc. (NASDAQ:OREX), A increase of 1,085,730 shares or 3.2% was observed in the short interest of Orexigen Therapeutics, Inc. The interest on August 14,2015 came in at 34,928,434 shares and as per the average daily trading of ...
Shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX) Sees Large Outflow of Money  News Watch International
Orexigen Therapeutics, Inc. (NASDAQ:OREX) Expected to Report $-0.17  Markets Daily
Why It's Lights Out for Orexigen Therapeutics, Inc.
What: Shares of Orexigen Therapeutics (NASDAQ:OREX), a biopharmaceutical company focused on developing therapies to treat obesity, saw its own valuation slim down by as much as 13% during Tuesday's trading session after it and its partner Takeda ...
Orexigen Therapeutics: A Bargain After Selloff On 'Bad News' (OREX)  Seeking Alpha
Are Problems at Orexigen Still Just Getting Started?  24/7 Wall St.
Orexigen Therapeutics, Inc. Goes From Biotech Beauty to Dreadful Drugmaker
Orexigen Therapeutics (NASDAQ:OREX) has been the darling of the obesity drugmakers, doing something Arena Pharmaceuticals (NASDAQ:ARNA) and VIVUS (NASDAQ:VVUS) weren't able to do: keep its share price above where it was when its ...
West Coast Biotech Roundup: Orexigen, Denali, Nant, ASCO & More  Xconomy
Why Orexigen Therapeutics Inc Stock Fell 18% in July
What: Investors in Orexigen Therapeutics (NASDAQ:OREX) stock were forced to swallow yet another bitter pill in July as shares of the biopharmaceutical company with a focus on obesity fell more than 18% during the month after marketing partner Takeda ...
Orexigen Therapeutics Upgraded to "Hold" by Zacks (OREX)  Dakota Financial News
Orexigen Therapeutics (OREX) Scheduled to Post Earnings on Thursday  WKRB News
Why Orexigen Therapeutics, Inc. Lost a Quarter of Its Value in May
What: Shares of Orexigen Therapeutics (NASDAQ:OREX), a small-cap drug developer focused on treating obesity, slimmed down and lost 25% of its value in May, based on data from S&P Capital IQ, after announcing bad news regarding its long-term ...
Can Orexigen Therapeutics, Inc. (NASDAQ:OREX) Keep Up with Analyst Expectations?
Orexigen Therapeutics, Inc. (NASDAQ:OREX) reported an earnings surprise of -20% when the company last reported earnings for the period ending on 2015-06-30.
Companies With High EPS Growth: Orexigen Therapeutics, Inc. (NASDAQ:OREX ...  Wall Street Observer
Hot Small Cap Stocks - Orexigen Therapeutics, Inc. (OREX), U.S. Silica ...  Techsonian (press release)
Orexigen Therapeutics, Inc. Analyst Rating Update
Analysts at Zacks have given a short term rating of sell on Orexigen Therapeutics, Inc. (NASDAQ:OREX) with a rank of 4. The company has received an average rating of 1.2 from 5 brokerage firms.
Company Shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX) Drops by -5.91%  Insider Trading Report
Orexigen Therapeutics, Inc. (NASDAQ:OREX) Analyst Rating in Focus  Investor Newswire
Why Orexigen Therapeutics, Inc. Lost a Sixth of Its Value in April
What: Shares of Orexigen Therapeutics (NASDAQ:OREX), a biopharmaceutical company engaged in the development of therapies for chronic weight management, lost 16% in April, or a sixth of its market value according to data from S&P Capital IQ, after it ...
Foresite Capital Betting It All On These Four Healthcare Stocks  Insider Monkey (blog)
Orexigen Therapeutics Receives Average Recommendation of "Buy" from Analysts ...
Orexigen Therapeutics logo Shares of Orexigen Therapeutics (NASDAQ:OREX) have been given a consensus rating of “Buy” by the eight ratings firms that are currently covering the firm, AnalystRatings.
Stock Update - Orexigen Therapeutics, Inc. (NASDAQ:OREX)  Vanguard Tribune
Healthcare Sector Movers: Orexigen Therapeutics, Inc. (OREX), Sucampo ...  WallStreet Scope